In reply

References

1. Beedham R. J., Turnbull P. C., Williamson E. D. 2001; Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine 19:4409–4416 [CrossRef]
   [Google Scholar]
2. Cote C. K., Van Rooijen N., Welkos S. L. 2006; Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect Immun 74:469–480 [CrossRef]
   [Google Scholar]
3. Enkhtuya J., Kawamoto K., Kobayashi Y., Uchida I., Rana N., Makino S.-i. 2006; Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids. Microbiology 152:3103–3110 [CrossRef]
   [Google Scholar]
4. Fasanella A., Losito S., Trotta T., Adone R., Massa S., Ciuchini F., Chiocco D. 2001; Detection of anthrax vaccine virulence factors by polymerase chain reaction. Vaccine 19:4214–4218 [CrossRef]
   [Google Scholar]
5. Goossens P. L., Sylvestre P., Mock M. 2007; Of spore opsonization and passive protection against anthrax. Microbiology 153:301–302 [CrossRef]
   [Google Scholar]
6. Ivins B. E., Hedlund K. W., Ristroph J. D., Leppla S. H., Ezzell J. W. Jr, Jemski, J. 1986; Immunization studies with attenuated strains of Bacillus anthracis . Infect Immun 52:454–458
   [Google Scholar]
7. Joyce J., Cook J., Chabot D., Hepler R., Shoop W., Xu Q., Stambaugh T., Aste-Amezaga M., Wang S. other authors 2006; Immunogenicity and protective efficacy of Bacillus anthracis poly- γ -d-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy. J Biol Chem 281:4831–4843 [CrossRef]
   [Google Scholar]
8. Koehler T. M. 2000; Bacillus anthracis. In Gram-Positive Pathogens pp 520 Edited by Fischetti V. A., Novik R. P., Ferretti J. J., Portnoy D. A., Rood J. I. Washington, DC: American Society for Microbiology;
   [Google Scholar]
9. Muscillo M., La Rosa G., Sali M., De Carolis E., Adone R., Ciuchini F., Fasanella A. 2005; Validation of a pXO2-A PCR assay to explore diversity among Italian isolates of Bacillus anthracis strains closely related to the live, attenuated Carbosap vaccine. J Clin Microbiol 43:4758–4765 [CrossRef]
   [Google Scholar]
10. Office International des Epizooties 2004 Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Paris: Office International des Epizooties;
    [Google Scholar]
11. Perkins S. D., Flick-Smith H. C., Garmory H. S., Essex-Lopresti A. E., Stevenson F. K., Phillpotts R. J. 2005; Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax. Genet Vaccines Ther 3:3 [CrossRef]
    [Google Scholar]
12. Phillips A. P., Martin K. L., Broster M. G. 1983; Differentiation between spores of Bacillus anthracis and Bacillus cereus by a quantitative immunofluorescence technique. J Clin Microbiol 17:41–47
    [Google Scholar]
13. Popov S. G., Popova T. G., Grene E., Klotz F., Cardwell J., Bradburne C., Jama Y., Maland M., Wells J. other authors 2004; Systemic cytokine response in murine anthrax. Cell Microbiol 6:225–233 [CrossRef]
    [Google Scholar]
14. Stopa P. J. 2000; The flow cytometry of Bacillus anthracis spores revisited. Cytometry 41:237–244 [CrossRef]
    [Google Scholar]
15. Welkos S. L., Cote C. K., Rea K. M., Gibbs P. H. 2004; A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J Microbiol Methods 56:253–265 [CrossRef]
    [Google Scholar]